Premium
New treatment for patients with advanced ovarian cancer receives accelerated approval
Author(s) -
Printz Carrie
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30714
Subject(s) - medicine , ovarian cancer , cancer , brca mutation , parp inhibitor , cancer research , oncology , clinical trial , poly adp ribose polymerase , gene , polymerase , genetics , biology